fbpx
Big Law

WeightWatchers Enters Into Prescription Weight Loss Business with New Acquisition

WeightWatchers’ stock soared Tuesday after the company said it is getting into the prescription drug weight loss business with the acquisition of Sequence.

Sequence is a telehealth provider that offers users access to drugs used to treat diabetes and obesity under the brand names including Ozempic, Wegovy and Trulicity. The drugs all work by the same mechanism: They trigger the release of insulin, block sugar production in the liver and suppress appetite.

WeightWatchers offers subscribers meal plans with the goal of losing excess weight. With the acquisition of Sequence, it is tapping into a red-hot market for prescription drugs that address obesity, and broadening what it offers to customers.

Read the source article at apnews.com

Leave a Review or Comment

Back to top button